Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use
article
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the effects of an oral contraceptive with ethinyl estradiol and dienogest on lipid metabolism over one year of conventional and extended use.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (3)
- Continuous use of oral contraceptives: an overview of effects and side‐effects 2012
- Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy 2011
- Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives 2010
References (28)
- Effect of dienogest-containing oral contraceptives on lipid metabolism via openalex
- doi:10.1056/nejmoa003216 via openalex
- doi:10.1210/jcem.80.6.7775629 via openalex
- doi:10.1159/000184610 via openalex
- doi:10.1016/j.contraception.2003.09.004 via openalex
- doi:10.1080/13625180600772741 via openalex
- doi:10.1016/j.maturitas.2003.10.013 via openalex
- doi:10.3109/13625189909085267 via openalex
- doi:10.1016/j.fertnstert.2006.11.206 via openalex
- doi:10.1016/0010-7824(90)90066-5 via openalex
- doi:10.1016/j.contraception.2004.06.001 via openalex
- doi:10.1016/0010-7824(92)90103-z via openalex
- doi:10.1067/mob.2002.122988 via openalex
- doi:10.1016/s0010-7824(98)00018-3 via openalex
- W2284956376 via openalex
- doi:10.2165/00003495-200464210-00006 via openalex
- doi:10.1016/0010-7824(94)90051-5 via openalex
- doi:10.1016/s0010-7824(98)00016-x via openalex
- doi:10.1016/j.tem.2004.06.006 via openalex
- W3023894528 via openalex
- doi:10.1097/00006254-200205000-00021 via openalex
- doi:10.1016/s0010-7824(03)00073-8 via openalex
- doi:10.3109/09513599609045648 via openalex
- doi:10.1016/j.contraception.2004.12.005 via openalex
- doi:10.1016/s0010-7824(98)00074-2 via openalex
- doi:10.1210/jc.80.6.1816 via openalex
- doi:10.1016/s0010-7824(00)00196-7 via openalex
- doi:10.1210/jc.2004-1958 via openalex
Cited by (3)
- Continuous use of oral contraceptives: an overview of effects and side‐effects 2012
- Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy 2011
- Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives 2010
Source provenance
- openalex
- last seen: 2026-05-14T06:04:04.317202+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK